Autoimmune Disease (SLE, Antiphospholipid Syndrome), Posttransplantation (Kidney, Liver, Heart, Bone Marrow), and Other Risk Factors (Chemotherapy, Caisson Disease, Radiation, Pancreatitis, Gaucher’s Disease)

13.

Horiuchi H, Hashikura Y, Hisa K, Saito N, Ikegami T, Nakazawa Y, et al. Osteonecrosis of the femoral head in Japanese adults after liver transplantation: a preliminary report. J Orthop Sci. 2004;9(2):119–21. doi:10.1007/s00776-003-0757-0.PubMedCrossRef

14.

Lieberman JR, Roth KM, Elsissy P, Dorey FJ, Kobashigawa JA. Symptomatic osteonecrosis of the hip and knee after cardiac transplantation. J Arthroplasty. 2008;23(1):90–6. doi:10.1016/j.arth.2007.01.006. S0883-5403(07)00045-9 [pii].PubMedCrossRef

15.

Tauchmanova L, De Rosa G, Serio B, Fazioli F, Mainolfi C, Lombardi G, et al. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review. Cancer. 2003;97(10):2453–61. doi:10.1002/cncr.11373.PubMedCrossRef

16.

Torii Y, Hasegawa Y, Kubo T, Kodera Y, Minami S, Morishita Y, et al. Osteonecrosis of the femoral head after allogeneic bone marrow transplantation. Clin Orthop Relat Res. 2001;382:124–32.PubMedCrossRef

17.

Winquist EW, Bauman GS, Balogh J. Nontraumatic osteonecrosis after chemotherapy for testicular cancer: a systematic review. Am J Clin Oncol. 2001;24(6):603–6.PubMedCrossRef

18.

Dzik-Jurasz AS, Brooker S, Husband JE, Tait D. What is the prevalence of symptomatic or asymptomatic femoral head osteonecrosis in patients previously treated with chemoradiation? A magnetic resonance study of anal cancer patients. Clin Oncol (R Coll Radiol). 2001;13(2):130–4.

19.

Toklu AS, Cimsit M. Dysbaric osteonecrosis in Turkish sponge divers. Undersea Hyperb Med. 2001;28(2):83–8.PubMed

20.

Hutter CD. Dysbaric osteonecrosis: a reassessment and hypothesis. Med Hypotheses. 2000;54(4):585–90. doi:10.1054/mehy.1999.0901. S0306-9877(99)90901-5 [pii].PubMedCrossRef

21.

Jones JP. Epidemiological risk factors for non-traumatic osteonecrosis. Orthopade. 2000;29(5):370–9.PubMed

22.

Rodrigue SW, Rosenthal DI, Barton NW, Zurakowski D, Mankin HJ. Risk factors for osteonecrosis in patients with type 1 Gaucher’s disease. Clin Orthop Relat Res. 1999;362:201–7.PubMedCrossRef

23.

Katz K, Horev G, Grunebaum M, Yosipovitch Z. The natural history of osteonecrosis of the femoral head in children and adolescents who have Gaucher disease. J Bone Joint Surg Am. 1996;78(1):14–9.PubMed

24.

Dubois EL, Cozen L. Avascular (aseptic) bone necrosis associated with systemic lupus erythematosus. JAMA. 1960;174:966–71.PubMedCrossRef

25.

Petri M. Musculoskeletal complications of systemic lupus erythematosus in the Hopkins Lupus Cohort: an update. Arthritis Care Res. 1995;8(3):137–45.PubMedCrossRef

26.

Gladman DD, Chaudhry-Ahluwalia V, Ibanez D, Bogoch E, Urowitz MB. Outcomes of symptomatic osteonecrosis in 95 patients with systemic lupus erythematosus. J Rheumatol. 2001;28(10):2226–9.PubMed

27.

Cozen L, Wallace DJ. Avascular necrosis in systemic lupus erythematosus: clinical associations and a 47-year perspective. Am J Orthop. 1998;27(5):352–4.PubMed

28.

Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. J Rheumatol. 1997;24(4):654–62.PubMed

29.

Aranow C, Zelicof S, Leslie D, Solomon S, Barland P, Norman A, et al. Clinically occult avascular necrosis of the hip in systemic lupus erythematosus. J Rheumatol. 1997;24(12):2318–22.PubMed

30.

Abeles M, Urman JD, Rothfield NF. Aseptic necrosis of bone in systemic lupus erythematosus. Relationship to corticosteroid therapy. Arch Intern Med. 1978;138(5):750–4.PubMedCrossRef

31.

Mok CC, Lau CS, Wong RW. Risk factors for avascular bone necrosis in systemic lupus erythematosus. Br J Rheumatol. 1998;37(8):895–900.PubMedCrossRef

32.

Gladman DD, Urowitz MB, Chaudhry-Ahluwalia V, Hallet DC, Cook RJ. Predictive factors for symptomatic osteonecrosis in patients with systemic lupus erythematosus. J Rheumatol. 2001;28(4):761–5.PubMed

33.

Zonana-Nacach A, Barr SG, Magder LS, Petri M. Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum. 2000;43(8):1801–8. doi:10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O.PubMed PubMedCrossRef

35.

Zizic TM, Marcoux C, Hungerford DS, Dansereau JV, Stevens MB. Corticosteroid therapy associated with ischemic necrosis of bone in systemic lupus erythematosus. Am J Med. 1985;79(5):596–604. 0002-9343(85)90057-9 [pii].PubMedCrossRef

36.

Klipper AR, Stevens MB, Zizic TM, Hungerford DS. Ischemic necrosis of bone in systemic lupus erythematosus. Medicine (Baltimore). 1976;55(3):251–7.CrossRef

37.

Weinstein RS. Glucocorticoid-induced osteonecrosis. Endocrine. 2012;41(2):183–90. doi:10.1007/s12020-011-9580-0.PubMedCentralPubMedCrossRef

38.

Calder JD, Buttery L, Revell PA, Pearse M, Polak JM. Apoptosis–a significant cause of bone cell death in osteonecrosis of the femoral head. J Bone Joint Surg Br. 2004;86(8):1209–13.PubMedCrossRef

39.

Seleznick MJ, Silveira LH, Espinoza LR. Avascular necrosis associated with anticardiolipin antibodies. J Rheumatol. 1991;18(9):1416–7.PubMed

40.

Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42(7):1309–11. doi:10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F.PubMed